BSX FY 2019 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10.7B+9.3% YoY

Gross Profit

$6.9B64.1% margin

Operating Income

$1.7B15.9% margin

Net Income

$4.7B43.8% margin

EPS (Diluted)

$3.33

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.4B

Stock-Based Comp.

$157M

Balance Sheet

Total Assets

$30.6B

Total Liabilities

$16.7B

Stockholders' Equity

$13.9B

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10.7B	$9.8B	+9.3%
Gross Profit	$6.9B	$6.5B	+6.2%
Operating Income	$1.7B	$1.7B	-1.4%
Net Income	$4.7B	$1.7B	+181.3%